蛛网膜下腔侵犯性垂体腺瘤的临床特征、影像学特点、手术管理与结局
该研究纳入2018至2024年连续436例经内镜经鼻、联合或开颅手术切除的垂体腺瘤,比较有与无蛛网膜下腔侵犯者的特征与结局。侵犯见于8%的肿瘤,影像上结节状侵犯、血管包绕及肿瘤更大更常见,全切率更低(49% vs 89%,p<0.00001),需额外干预更多(40% vs 13%,p<0.0001),术后血肿、穿支梗死、需分流脑积水及永久性激素缺乏更常见;基于多因素分析构建的NETS评分≥3分预测侵犯的敏感性91%、阴性预测值99%。
要点
- 蛛网膜下腔侵犯见于8%切除的垂体腺瘤,全切率显著低于无侵犯者(49% vs 89%)。
- 侵犯者需额外干预比例更高(40% vs 13%),术后血肿、穿支梗死、脑积水及永久激素缺乏风险增加。
- NETS评分≥3分预测侵犯敏感性91%、阴性预测值99%,可辅助术前识别与手术规划。
核心结论
- 蛛网膜下腔侵犯性垂体腺瘤因毗邻关键神经血管结构而并发症率高,NETS评分可高敏感地术前预测侵犯并辅助手术规划。
研究设计与样本
- 回顾性收集2018至2024年连续436例经内镜经鼻、联合内镜经鼻/开颅或开颅手术切除的垂体腺瘤,比较有与无蛛网膜下腔侵犯者的临床特征、影像特点与结局。
主要发现
- 蛛网膜下腔侵犯见于8%的切除垂体腺瘤。
- 侵犯者影像上结节状侵犯、蛛网膜下腔血管包绕及肿瘤尺寸增加。
- 既往手术干预及促肾上腺皮质激素/泌乳素细胞组织学为侵犯的显著危险因素。
- 侵犯者全切率更低(49% vs 89%,p<0.00001),需额外干预更多(40% vs 13%,p<0.0001)。
- 侵犯者术后血肿(p=0.05)、穿支梗死(p<0.01)、需分流脑积水(p<0.001)、永久性血管加压素缺乏(p<0.01)及需永久激素替代的肾上腺功能不全(p=0.02)增加。
关键数值与推荐
- NETS评分:结节状侵犯2分、蛛网膜下腔血管包绕2分、最大肿瘤直径>20 mm 1分、既往手术干预史1分。
- NETS评分≥3分预测蛛网膜下腔侵犯的敏感性91%、阴性预测值99%。
- 侵犯者手术方式:内镜经鼻80%、联合内镜经鼻/开颅14%、开颅6%。
临床怎么用
- 对拟手术垂体腺瘤术前计算NETS评分,≥3分提示蛛网膜下腔侵犯可能,应据此规划扩大暴露与精细显微分离。
- 对评分高危者应预期全切率较低、需额外干预及术后血肿、穿支梗死、脑积水和永久激素缺乏风险增加,做好围手术期准备与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A subset of pituitary adenomas invade the subarachnoid space, encase critical neurovascular structures, and portend significant surgical morbidity. Resection of these lesions requires a modified surgical approach involving an expanded bony exposure and meticulous microsurgical dissection to avoid injury to the involved neurovascular structures. The goal of this study was to elucidate the clinical and radiographic features of subarachnoid adenomas and to characterize the outcomes after resection of these challenging tumors. METHODS: Data were collected from 436 consecutive pituitary adenomas that underwent endoscopic endonasal approaches (EEAs), combined EEA/open transcranial approaches, and open transcranial approaches for tumor resection from 2018 to 2024. Clinical features, imaging characteristics, and clinical outcomes were compared across tumors with and without subarachnoid invasion. RESULTS: Subarachnoid invasion was identified in 8% of pituitary adenomas that underwent resection. Compared to adenomas without subarachnoid invasion, subarachnoid adenomas demonstrated increased nodular invasion, subarachnoid vessel encasement, and tumor size on imaging. Prior surgical intervention and corticotroph/lactotroph histology were significant risk factors for subarachnoid invasion. EEA was the primary surgical approach utilized for resection (80%), although combined EEA/open transcranial (14%) and open transcranial approaches (6%) were also utilized for subarachnoid adenomas. Gross-total resection rates were lower for subarachnoid adenomas (49% vs 89%, p < 0.00001), and patients with subarachnoid adenomas were more likely to require additional interventions (40% vs 13%, p < 0.0001). Tumors with subarachnoid invasion were also associated with increased postoperative hematomas (p = 0.05), perforator infarcts (p < 0.01), and postoperative hydrocephalus requiring shunt placement (p < 0.001). In addition, subarachnoid adenomas were associated with increased rates of permanent vasopressin deficiency (p < 0.01) and adrenal insufficiency requiring permanent hormone replacement (p = 0.02). Based on multivariate analysis, the NETS score was developed to preoperatively predict subarachnoid invasion, incorporating nodular invasion (2 points), subarachnoid vessel encasement (2 points), maximum tumor diameter > 20 mm (1 point), and history of prior surgical intervention (1 point). NETS scores ≥ 3 demonstrated 91% sensitivity and 99% negative predictive value for subarachnoid invasion. CONCLUSIONS: Subarachnoid adenomas are associated with high morbidity due to their close association with critical neurovascular structures. Invasive tumor biology and prior arachnoid disruption likely contribute to the nodular invasion and subarachnoid vessel encasement that are characteristic of these challenging tumors. The NETS score is a highly sensitive predictive score that can assist in preoperative identification and facilitate appropriate surgical planning.
引用
- Lamano JB, Banu MA, Lee CK, et al. Pituitary adenomas with subarachnoid invasion: clinical characteristics, radiographic features, surgical management, and outcomes. J Neurosurg. 2026. PMID: 42468041. doi:10.3171/2026.2.JNS251912
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。